Fouad Alchami
Cardiff and Vale University Health Board(GB)Qatar Airways (Qatar)(QA)Weill Cornell Medical College in Qatar(QA)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Cancer-related Molecular Pathways, Occupational and environmental lung diseases, Microtubule and mitosis dynamics, PARP inhibition in cancer therapy
Most-Cited Works
- → Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial(2020)223 cited
- → Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study(2018)95 cited
- → Synergistic targeting of breast cancer stem‐like cells by human γδ T cells and CD8+ T cells(2017)61 cited
- → Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP(2018)55 cited
- → Capivasertib (AZD5363) plus fulvestrant versus placebo plus fulvestrant after relapse or progression on an aromatase inhibitor in metastatic ER-positive breast cancer (FAKTION): A randomized, double-blind, placebo-controlled, phase II trial.(2019)38 cited
- → Myxoid variant epithelioid pleural mesothelioma defines a favourable prognosis group: an analysis of 191 patients with pleural malignant mesothelioma